top of page
PharmacoExcellence, LLC

Pharmacokinetics and Pharmacodynamics 

Design and Analysis for Clinical Trials

Clinical Development Services

Pharmacokinetic and Pharmacodynamic Design and Analysis Solutions for Phase 1 - 3 Clinical Studies

Non-compartmental Analysis

Small and Large Molecule

Intravenous | Injectable

Oral | Buccal | Modified Release

Pulmonary Drug Delivery

Modeling and Simulation

Population Pharmacokinetics


Concentration / Effect

Clinical Trial Simulation

In-vitro / in-vivo Correlation

Clinical Study Design

Bioavailability | Bioequivalence Biosimilarity

Formulation Development

Food Effect | Mass Balance 

Drug-Drug Interactions

Single / Multiple Ascending Dose



Scott Brittain, PhD

Scott Brittain is the founder of PharmacoExcellence, LLC, a company specializing in pharmacokinetic and pharmacodynamic modeling and simulation.  Scott earned his PhD in chemistry at Harvard University and has been in the pharmaceutical industry for 15 years, most recently as the head of clinical research for Supernus Pharmaceuticals, Inc.  He has extensive experience in clinical pharmacology and clinical program development, including protocol design and data analysis.  Scott has specialized knowledge of modeling and simulation methods including noncompartmental analysis (NCA), population pharmacokinetics using non-linear mixed effects modeling (NONMEM), concentration-effect (PK/PD) modeling, clinical trials simulation and in-vitro in-vivo correlation (IVIVC).   






PharmacoExcellence, LLC

21 Ferry Landing Ln NW Unit 1401

 Atlanta, GA USA

  • White LinkedIn Icon

Success! Message received.

bottom of page